Accumulating evidence indicates that NETs may fight against tissue-type plasminogen activator (t-PA) by promoting coagulation and stabilizing clot-induced thrombosis, which is a problem often encountered in the treatment of patients with stroke (47–49). This evidence concerns the gene PLAT and stroke disorder.